Evecxia co-founder Jacob Jacobsen has been appointed to serve as the biotech’s chief scientific officer. Jacobsen was most recently a scientist in the Duke University lab of Marc Caron, another co-founder of Research Triangle Park, NC-based Evecxia. His industry experience includes positions at Lundbeck and NeuroSearch. Evecxia’s lead therapeutic candidate, EVX-101, is in development as a treatment for depression.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
